GLORIA MELANIE (Chief Operating Officer) sold 3.4% of their position (8.72K shares) of IMMUNOVANT, INC. on the open market
Open‑market sale worth $216.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/10/2026ACC: 0001973838-26-000004
Officer· Chief Operating Officer
Since Feb 2026
-8.72K
Net shares
Net seller
$216.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
8.72K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−8.72K
Price / share
$24.83
Trade value
$216.57K
% of position
3.4%
4/8/2026
253.94K→245.22K
Total
Net shares
−8.72K
Net value
-$216.57K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/8/2026 | S · Sale | −8.72K | $24.83 | $216.57K | 3.4% | 253.94K | 245.22K |
| Total | −8.72K | -$216.57K | ||||||
Derivative Transactions0
No derivative transactions reported